An overview of growth factors as the potential link between psoriasis and metabolic syndrome.

Mateusz Matwiejuk, Adrian Chabowski, Iwona Flisiak, Hanna Myśliwiec

Published: 2023-11-02 DOI: 10.17504/protocols.io.6qpvr3rwzvmk/v1

Abstract

Psoriasis

is a chronic, complex, immunologically mediated, systematic disease that can

not only affect the skin but also the joints, and nails. It may coexist with

various other disorders such as depression, psoriatic arthritis, cardiovascular

diseases, diabetes mellitus, and metabolic syndrome. In particular, the

potential link between psoriasis and metabolic syndrome is worthy of an

attention issue. A dysregulated level of growth factors could potentially

contribute to the disturbances of keratinocyte proliferation, inflammation, and

severity of itch. However, the

pathophysiology of psoriasis and its comorbidities, such as metabolic syndrome,

remain incompletely elucidated. Growth factors and their abnormal metabolism may

be the potential link connecting this conditions. Overall, the objective of

this review is to analyze the role of growth factors disturbances in psoriasis

and in metabolic syndrome.

Attachments

Steps

1.

Identification of records. Databases (n = 1) Pubmed

2.

Screening of records

Records screened (n = 1579)

3.

Records excluded (n = 1372 )

No data available

Abstracts

4.

Reports assesed for eligibility (n = 207 )

5.

Reports excluded

Reason 1 (n = 38 ) Duplications

Reason 2 (n = 77 ) Out of scope

6.

Studies included in review (n = 92 )

9.

Records

identified

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询